testnews
Syndication, testnews »
Santarus Inc. Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering |  |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO–(BUSINESS WIRE)–Santarus, Inc. (NASDAQ: SNTS) today announced the completion of a secondary underwritten public offering of 4,887,500 shares of its c…
More...Syndication, testnews »
Illumina, Inc. Launches BaseSpace® Apps | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced the full commercial availability of BaseSpace, the Companys genomics cloud computing and…
More...Syndication, testnews »
Ambit Biosciences Cuts IPO Price | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Ambit Biosciences Announces Pricing of Initial Public OfferingSAN DIEGO, May 16, 2013 /PRNewswire/ — Ambit Biosciences Corporation today announced the…
More...Syndication, testnews »
Halozyme Therapeutics, Inc. to Present New Data on PEGPH20 In Pancreatic Cancer at American Society of Clinical Oncology Annual Meeting | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 15, 2013 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that clinical data…
More...Syndication, testnews »
Receptos to Deliver Scientific Presentations at About the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease | |
|
Posted by sandiegobiotech May 16th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 15, 2013 (GLOBE NEWSWIRE) — Receptos (Nasdaq:RCPT) today announced that Company personnel will deliver three scientific poster presentations abou…
More...Syndication, testnews »
San Diego’s RuiYi (aka Anaphore) Focuses Anew on Antibodies & China | |
|
Posted by sandiegobiotech May 15th, 2013 .
| |
| No Comments |
It’s been almost two years since Paul Grayson was named as CEO of San Diego’s Anaphore—more than enough time for the former Fate Therapeutics CEO to put a new strategy in place. The company…
[[Click headline to continue reading.]]
Syndication, testnews »
Atlas Leans on Amgen, Novartis to Build New Startups | |
|
Posted by sandiegobiotech May 15th, 2013 .
| |
| No Comments |
Fresh off raising $265 million to bankroll its ninth fund, Atlas Venture has forged strategic partnerships with Amgen and Novartis to help supply the bigger companies with innovative new drug…
[[Click headline to continue reading.]]
More...Syndication, testnews »
Cardium Therapeutics, Inc. Presents First Quarter 2013 Financial Results and Reports on Recent Developments | |
|
Posted by sandiegobiotech May 15th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO, May 15, 2013 /PRNewswire/ — Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the first quarter ended March 31, 2013, an…
More...Syndication, testnews »
ACADIA Pharmaceuticals, Inc. Prices Public Offering of Common Stock | |
|
Posted by sandiegobiotech May 15th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the pricing of an underwritten public offering of 8,000,000 shares of its …
More...Syndication, testnews »
ACADIA Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock | |
|
Posted by sandiegobiotech May 15th, 2013 .
| |
| No Comments |
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions,…
More...
